12 June 2025

cardiovascular Clinical research Pharmaceuticals Rheumatoid Arthritis

Upadacitinib outperforms adalimumab regardless of CV risk

29 May 2025

Lupus Scleroderma

New immune-based CAR T therapy side effect identified

29 May 2025

Pharmaceuticals Systemic sclerosis

Treating scleroderma is like choosing your own adventure

29 May 2025

ARA Guidelines

What’s in a name?

15 May 2025

Clinical research Dermatology Pharmaceuticals Plaque psoriasis

Foam treatment reduces scalp and body psoriasis

15 May 2025

Conferences RACP Workforce

What does the new rheumatology curriculum look like?

15 May 2025

Cancer Conferences Pharmaceuticals Rheumatology

The great checkpoint inhibitor balancing act

15 May 2025

Cardiovascular disease Conferences Guidelines Systemic sclerosis

Keep the heart front of mind in systemic sclerosis

1 May 2025

ARA Conferences Systemic sclerosis

Putting systemic sclerosis under the microscope

17 April 2025

ARA Conferences

ARA 2025: ‘A festival of rheumatology’

17 April 2025

Respiratory

Tezepelumab reduces polyps, congestion in chronic rhinosinusitis

17 April 2025

Pharmaceuticals Research

Inebilizumab gets IgG4-related disease nod from FDA

17 April 2025

Exercise Osteoarthritis

Aussie trial shows yoga ‘an alternative’ in knee OA

3 April 2025

Diagnosis Polymyalgia Rheumatica

Vascular ultrasound ‘speculative’ for polymyalgia rheumatica

20 March 2025

Pharmaceuticals Psoriatic Athritis

Secukinumab helps bone health in PsA

6 March 2025

PBS Psoriatic Athritis

PBS rizz for new psoriatic arthritis drug